ResearcherSecond Affiliated Hospital of Chongqing Medical UniversityActive in the last 2 years
Kun Zhou
Matched on ORCID iD 0000-0002-1599-8630; OpenAlex author ID A5068398133. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers
Papers 6
- High-Intensity Focused Ultrasound Ablation Combined With Pharmacogenomic-Guided Chemotherapy for Advanced Pancreatic Cancer: Initial Experience. Co-author DOI 10.1016/j.ultrasmedbio.2024.06.013↗
- US-guided high-intensity focused ultrasound in pancreatic cancer treatment: a consensus initiative between Chinese and European HIFU centers. Co-author DOI 10.1080/02656736.2023.2295812↗
- Is high-intensity focused ultrasound (HIFU) an option for neoadjuvant therapy for borderline resectable pancreatic cancer patients? - a systematic review. Co-author DOI 10.1080/02656736.2021.1909150↗
- Recurrent pancreatic cancer patient treated by chemotherapy and focused ultrasound surgery. A case report. Last author DOI 10.11152/mu-2031↗
- Effects of high-intensity focused ultrasound treatment on peripancreatic arterial and venous blood vessels in pancreatic cancer. Co-author DOI 10.3892/ol.2020.11511↗
- Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e31821fde24↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dobromir Dimitrov Dimitrov · 4 shared papers, 2020–2024 · strength 0.64
- Paper US-guided high-intensity focused ultrasound in pancreatic cancer treatment: a consensus initiative between Chinese and … DOI 10.1080/02656736.2023.2295812↗
- Paper Recurrent pancreatic cancer patient treated by chemotherapy and focused ultrasound surgery. A case report. DOI 10.11152/mu-2031↗
- Paper Is high-intensity focused ultrasound (HIFU) an option for neoadjuvant therapy for borderline resectable pancreatic canc… DOI 10.1080/02656736.2021.1909150↗
- Chengbing Jin · 2 shared papers, 2020–2024 · strength 0.35
- Paper High-Intensity Focused Ultrasound Ablation Combined With Pharmacogenomic-Guided Chemotherapy for Advanced Pancreatic Ca… DOI 10.1016/j.ultrasmedbio.2024.06.013↗
- Paper Effects of high-intensity focused ultrasound treatment on peripancreatic arterial and venous blood vessels in pancreati… DOI 10.3892/ol.2020.11511↗
- Lifeng Ran · 2 shared papers, 2020–2024 · strength 0.35
- Paper High-Intensity Focused Ultrasound Ablation Combined With Pharmacogenomic-Guided Chemotherapy for Advanced Pancreatic Ca… DOI 10.1016/j.ultrasmedbio.2024.06.013↗
- Paper Effects of high-intensity focused ultrasound treatment on peripancreatic arterial and venous blood vessels in pancreati… DOI 10.3892/ol.2020.11511↗
- Jun Zhang · 2 shared papers, 2020–2024 · strength 0.35
- Paper High-Intensity Focused Ultrasound Ablation Combined With Pharmacogenomic-Guided Chemotherapy for Advanced Pancreatic Ca… DOI 10.1016/j.ultrasmedbio.2024.06.013↗
- Paper Effects of high-intensity focused ultrasound treatment on peripancreatic arterial and venous blood vessels in pancreati… DOI 10.3892/ol.2020.11511↗
- Nadya Stanislavova · 2 shared papers, 2020–2021 · strength 0.32
- Xing Chen · 1 shared paper, 2024 · strength 0.24
- Joan Vidal-Jové · 1 shared paper, 2024 · strength 0.21
- Milka Marinova · 1 shared paper, 2024 · strength 0.21
- Holger M. Strunk · 1 shared paper, 2024 · strength 0.21
- Maria Angeles Gonzalez-Carmona · 1 shared paper, 2024 · strength 0.21
- Xiaoyin Guo · 1 shared paper, 2020 · strength 0.11
- Joon‐Yeol Han · 1 shared paper, 2011 · strength 0.02
- Young Sok Lee · 1 shared paper, 2011 · strength 0.02
- Hye Young Sung · 1 shared paper, 2011 · strength 0.02
- Seung Eun Jung · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.